Covid-19. Covid-19 infection
Conditions
Interventions
Intervention 1: Intervention group: In addition to national protocol medications, patients receive 40 mg of melatonin (Simorgh Pharmaceutical Company)
(2 tablets, 5 mg every 6 hours) via NG tube. Patients will also receive 2 grams of ascorbic acid per day at 5% dextrose(Daropakhsh Company) every 6 hours, plus 220 mg of sulfate every 6 hours(Alhawi C
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: Patients with Covid 19 Conscious consent of the patient
Exclusion criteria
Exclusion criteria: Malignant diseases Severe renal, hepatic failure History of drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of breaths per minute. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Vital signs monitoring devices.;The rate of decline of lung infection. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Clinical examination, if necessary, radiography or CT scan.;The course of the disease. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Clinical examination, if necessary, radiography or CT scan.;Heart rate. Timepoint: Before the intervention, from the start of treatment to the patient's recovery. Method of measurement: Vital signs monitoring devices. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboubeh Darban
Semnan University of Medical Sciences
Outcome results
None listed